Differences

This shows you the differences between two versions of the page.

--- triaging_pdl1_3d_requests [2026/04/07 19:58] – gilbert
+++ triaging_pdl1_3d_requests [2026/04/07 20:40] (current) – removed gilbert
@@ Line 1: / Line 1: @@
-====== Gastrointestinal Biomarkers ======
-<WRAP center 100%>
-^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
-| **PD-L1** | Gastric, GEJ, esophageal \\ adenocarcinoma; ESCC | Pembrolizumab, \\ Nivolumab | PDL1 Dako 22C3 \\ PharmDX | ''PDL1UPPERGIMARCH2026'' |
-| **Claudin 18.2** | Gastric or GEJ \\ adenocarcinoma | Zolbetuximab | VENTANA CLDN18 \\ (43-14A) RxDx | ''BMCLAUDIN18'' |
-</WRAP>
-====== Head & Neck Biomarkers ======
-<WRAP center 100%>
-^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
-| **PD-L1** | Head and neck squamous \\ cell carcinoma (HNSCC) | Pembrolizumab | PDL1 Dako 22C3 \\ PharmDX | ''PDL1HNSCC22C3PEMBRO'' |
-</WRAP>
-====== Gyne Biomarkers ======
-<WRAP center 100%>
-^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
-| **PD-L1** | Cervical cancer \\ (SCC and Adenocarcinoma) | Pembrolizumab | PDL1 Dako 22C3 \\ PharmDX | ''PDL1CERVIX'' |
-| **CEP17 SISH** | Ploidy Analysis | N/A | VENTANA Inform \\ Chromosome 17 probe | ''MOLARCEP17'' |
-</WRAP>
-====== Lung Biomarkers ======
-<WRAP center 100%>
-^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
-| **PD-L1** | NSCLC stage II to IIIA | Atezolizumab | PDL1 SP263 | ''PDL1NSCLCATEZOSP263'' |
-</WRAP>
-====== Breast Biomarkers ======
-<WRAP center 100%>
-^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^
-| **PD-L1** | Triple Negative Breast \\ Cancer (TNBC) | Pembrolizumab | PDL1 Dako 22C3 \\ PharmDX | ''PDL1TNBC22C3PEMBRO'' |
-</WRAP>